Triple
T3382147
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Virchow's triad |
E71209
|
entity |
| Predicate | hasClinicalSignificance |
P47123
|
FINISHED |
| Object | guides prevention of venous thromboembolism |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: guides prevention of venous thromboembolism | Statement: [Virchow's triad, hasClinicalSignificance, guides prevention of venous thromboembolism]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasClinicalSignificance Context triple: [Virchow's triad, hasClinicalSignificance, guides prevention of venous thromboembolism]
-
A.
hasSignificant
Indicates that one entity possesses or exhibits a level of importance, impact, or relevance that is notably large or meaningful in relation to another entity or context.
-
B.
hasPreclinicalFeature
Indicates that an entity exhibits a characteristic, sign, or attribute that is present before the full clinical manifestation of a condition or disease.
-
C.
isGloballySignificant
Indicates that something has importance, impact, or relevance on a worldwide scale rather than being limited to a local or regional context.
-
D.
hasPrognosis
Indicates that one entity (typically a medical condition or case) is associated with an expected course or outcome over time, such as likely progression, duration, or chances of recovery.
-
E.
hasContraindication
Indicates that one entity (such as a treatment, drug, or procedure) should not be used or performed in the presence of another entity (such as a condition, factor, or co-medication) because it may cause harm or adverse effects.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ad85a8fd9c819095ecedf838d2bf1b |
completed | March 8, 2026, 2:20 p.m. |
| NER | Named-entity recognition | batch_69adb5e9af608190bfb228ef99a87bb7 |
completed | March 8, 2026, 5:46 p.m. |
| PD | Predicate disambiguation | batch_69ada434bae48190a77ea37f9274ad8f |
completed | March 8, 2026, 4:30 p.m. |
| PDg | Predicate description generation | batch_69ada527ff308190813a7ffdcdec4322 |
completed | March 8, 2026, 4:34 p.m. |
Created at: March 8, 2026, 3:14 p.m.